Results 191 to 200 of about 9,966 (258)

Desflurane Safety Revisited: A Pharmacovigilance Study Detecting Potential Safety Signals from FAERS Data. [PDF]

J Pain Res
Wei W, Chen L, Ying X.
europepmc   +1 more source

Analysis of Adverse Drug Reactions of Clofazimine Reported in the FDA Adverse Event Reporting System from 2004 to 2025 Q1. [PDF]

Infect Dis Ther
Zhang R, Tao Y, Bao Z, Zhang J, Zeng L, Fang C, Wu M.   +6 more
europepmc   +1 more source

Adverse events associated with Lutetium-177-PSMA-617 (Pluvicto^®) in advanced prostate cancer: a disproportionality analysis based on the fda's adverse event reporting system (FAERS). [PDF]

BMC Cancer
Jin Y, Zhang Y, Wang M, Bai X, Ping H, Xing N.   +5 more
europepmc   +1 more source

Dupilumab and the potential risk of eosinophilic pneumonia: case report, literature review, and FAERS database analysis [PDF]

Xiyuan Zhou, Ge Yang, Xuemei Zeng, Lan Wang, Jing Xiang, Jinyu Zhao, Xuejun Chen, Lixia Zhang   +7 more
openalex   +1 more source

Real-World Safety Concerns of Tirzepatide: A Retrospective Analysis of FAERS Data (2022-2025). [PDF]

Healthcare (Basel)
Almansour HA, Thaibah HA, Alfarhan M, Al-Qahtani SA, Khardali AA, Alshammari TM.   +5 more
europepmc   +1 more source

Real-world large sample evaluation of drug-related blepharoptosis: a pharmacovigilance analysis of the FDA Adverse Event Reporting System database. [PDF]

Ther Adv Drug Saf
Xiao K, Chen X, Wu S, Zhang Y, Chen R, Wu H, Qi Z, Liu J, Wang Y, Miao Y, Huang Y, Li L.   +11 more
europepmc   +1 more source

Adverse event signal mining and serious adverse event influencing factor analysis of fulvestrant based on FAERS database [PDF]

Guisen Yin, Guiling Song, Shuyi Xue, Fen Liu   +3 more
openalex   +1 more source

FAERS based disproportionality analysis and network pharmacology investigation of doxorubicin associated drug induced cardiotoxicity. [PDF]

Sci Rep
Lu J, Shen C, Ma W, Lin Z, Gao W.
europepmc   +1 more source

Trimethoprim/sulfamethoxazole and risk of haemophagocytic lymphohistiocytosis (HLH): a literature review and disproportionality analysis using individual case safety reports from FAERS. [PDF]

J Antimicrob Chemother
Lau R, Sadeghi H, Ahmadi F, Chalabianloo N, Preyra R, Omrani MA, Muanda FT.   +6 more
europepmc   +1 more source

Exploring drug-induced pemphigus findings from the FDA adverse event reporting system database. [PDF]

Medicine (Baltimore)
Niu Y, Lu H, He L, Wang Z, Duan X.
europepmc   +1 more source